Cabergoline

Cabergoline by Zyntex is a potent, long-acting dopamine receptor agonist (CAS 81409-90-7). It is the primary treatment for hyperprolactinemia and related hormonal imbalances. It offers high precision for pharmaceutical formulations and clinical studies.

SKU: 81409-90-7 Category: Tags: ,
Description
Cabergoline is a highly potent and long-acting ergoline derivative. Zyntex supplies this premium active pharmaceutical ingredient (API) for global endocrine research and medicine production. This white crystalline powder (CAS 81409-90-7) acts as a selective dopamine D2 receptor agonist. It effectively inhibits the secretion of prolactin from the pituitary gland. In addition, it possesses a long half-life for sustained biological activity. Therefore, laboratories use it to treat hormonal disorders, Parkinson’s disease, and specialized metabolic conditions.

Comprehensive Product Overview

Precise dopamine receptor targeting provides a major advantage in hormone regulation. Cabergoline works by mimicking the action of dopamine to reduce high prolactin levels. It restores the natural balance of the endocrine system. For instance, it is the gold standard for treating prolactin-secreting tumors (prolactinomas). Consequently, it helps patients manage symptoms like infertility and menstrual irregularities. As a result, Zyntex ensures the highest pharmaceutical purity for our Cabergoline supply. This ensures maximum stability and consistent dosage performance in clinical applications.

Moreover, Zyntex provides Cabergoline for the management of early-stage Parkinson’s disease. It helps alleviate motor symptoms by stimulating dopamine pathways in the brain. This application pushes the boundaries of modern neurology. At the same time, it serves as a critical tool for researchers studying the hypothalamic-pituitary-adrenal axis. In short, our product serves as a “high-precision hormonal regulator.” It supports both advanced clinical endocrinology and neuro-pharmacological innovation.

Recently, scientific interest in Cabergoline for its metabolic effects on glucose and lipids has grown. It shows potential in improving insulin sensitivity in specific patient groups. Because of this, Zyntex offers specialized pharmaceutical-grade formats for ongoing clinical trials. These formats suit modern medical research facilities. Ultimately, choosing Zyntex secures a reliable and high-purity API supply chain. We balance molecular precision with rigorous batch testing. To conclude, our commitment ensures your pharmaceutical products achieve the highest levels of medical efficacy and safety.

Key Industrial Applications

This potent dopamine agonist is vital in these four sectors:

🩺 Endocrinology

The primary treatment for hyperprolactinemia. Thus, it provides a powerful solution for balancing pituitary hormones.

🧠 Neurology

Used as an adjuvant therapy in Parkinson’s disease. Consequently, it helps improve muscle control and reduce tremors.

🧪 Clinical Research

Essential reagent for studying dopamine receptor signaling. Undoubtedly, it is a key tool for modern neuro-endocrine research.

💊 Pharma Manufacturing

Used to produce high-efficacy tablets and capsules. Specifically, it requires extreme precision due to its high biological potency.

Technical Specifications

ParameterStandard Value
Product NameCabergoline (Pharmaceutical Grade)
Assay / PurityMin. 98.5% (HPLC)
Molecular FormulaC26H37N5O2
CAS Number81409-90-7

⚠️ Handling Note: Cabergoline is an extremely potent compound. Even microgram quantities are biologically active. Therefore, handle with absolute care in a controlled laboratory environment. Wear full PPE and ensure high-containment during weighing and processing.